Real-Life Effectiveness and Tolerance of Upadacitinib for Severe Atopic Dermatitis in Adolescents and Adults

被引：0
|
作者：
Axel De Greef
Pierre-Dominique Ghislain
Laurence de Montjoye
Marie Baeck
机构：
[1] Cliniques Universitaires Saint-Luc (UCLouvain),Department of Dermatology
来源：
Advances in Therapy | 2023年 / 40卷
关键词：
Atopic dermatitis; Real-life study; JAK inhibitor; Upadacitinib; Effectiveness; Tolerance;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2509 / 2514
页数：5
相关论文
共 50 条
  • [21] EFFECTIVENESS AND TOLERANCE OF JANUS KINASE INHIBITORS FOR THE TREATMENT OF RECALCITRANT ATOPIC DERMATITIS IN A REAL-LIFE FRENCH MULTICENTER ADULT COHORT
    Vanlerberghe, Julia
    Dezoteux, Frederic
    Martin, Claire
    Jachiet, Marie
    Soria, Angele
    Tetart, Florence
    Modeste-Duval, Anne-Benedicte
    Bursztejn, Anne-Claire
    Misery, Laurent
    Aubin, Francois
    Lasek, Audrey
    Leleu, Camille
    Du-Thanh, Aurelie
    Pasteur, Justine
    Pralong, Pauline
    Nosbaum, Audrey
    Droitcourt, Catherine
    Viguier, Manuelle
    Tauber, Marie
    Seneschal, Julien
    Barbarot, Sebastien
    Staumont-Salle, Delphine
    ACTA DERMATO-VENEREOLOGICA, 2022, 102 : 28 - 28
  • [22] Effectiveness and tolerance of Janus kinase inhibitors for the treatment of recalcitrant atopic dermatitis in a real-life French multicenter adult cohort
    Vanlerberghe, Julia
    Dezoteux, Frederic
    Martin, Claire
    Jachiet, Marie
    Soria, Angele
    Tetart, Florence
    Modeste-Duval, Anne-Benedicte
    Bursztejn, Anne-Claire
    Misery, Laurent
    Aubin, Francois
    Lasek, Audrey
    Leleu, Camille
    Du-Thanh, Aurelie
    Pasteur, Justine
    Pralong, Pauline
    Nosbaum, Audrey
    Droitcourt, Catherine
    Viguier, Manuelle
    Tauber, Marie
    Seneschal, Julien
    Barbarot, Sebastien
    Staumont-Salle, Delphine
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 88 (04) : 900 - 904
  • [23] Network meta-analysis on the efficacy and safety of upadacitinib in adolescents and adults with moderate-to-severe atopic dermatitis
    Qiu, Mei
    Duan, Xue-Yan
    Yin, Dao-Gen
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2022, 61 (01) : E24 - E26
  • [24] REAL-LIFE CASE-SERIES EXPERIENCE WITH TRALOKINUMAB IN PATIENTS WITH SEVERE ATOPIC DERMATITIS
    Caroppo, Francesca
    Fortina, Anna Belloni
    ACTA DERMATO-VENEREOLOGICA, 2023, 103 : 20 - 21
  • [25] Prolonged real-life experience with baricitinib in patients with moderate-to-severe atopic dermatitis
    De Greef, Axel
    Ghislain, Pierre-Dominique
    Baeck, Marie
    EUROPEAN JOURNAL OF DERMATOLOGY, 2023, 33 (06) : 707 - 709
  • [26] Real-life case-series experience with tralokinumab in patients with severe atopic dermatitis
    Caroppo, Francesca
    Belloni Fortina, Anna
    JEADV CLINICAL PRACTICE, 2024, 3 (01): : 296 - 300
  • [27] Real-world use and effectiveness of upadacitinib in adults and adolescents with atopic dermatitis: preliminary analysis of the real-world multicountry AD-VISE study
    Lima, Hermenio
    Pereyra-Rodriguez, Jose-Juan
    Beecker, Jennifer
    Lynde, Charles W.
    Sancho, Cristina
    Lane, Michael
    Wang, Hongwei
    Calimlim, Brian M.
    Armendariz, Yolanda
    Gooderham, Melinda J.
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 190 : II7 - II8
  • [28] Real-life long-term efficacy of dupilumab in adults with moderate to severe atopic dermatitis: Results of a cohort study
    Guedon, C.
    Tauber, M.
    Linder, C.
    Paul, C.
    Shourick, J.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2023, 150 (03): : 215 - 216
  • [29] A real-world Australian experience of upadacitinib for the treatment of severe atopic dermatitis
    Tran, Vanessa
    Ross, Gayle
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2023, 64 (04) : e352 - e356
  • [30] REAL-LIFE EXPERIENCE IN THE EFFECTIVENESS , IMPACT ON QUALITY OF LIFE AND SAFETY OF DUPILUMAB TREATMENT IN PATIENTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS IN THE CZECH REPUBLIC
    Tanczosova, Milena
    Kojanova, Martina
    Arenbergerova, Monika
    Arenberger, Petr
    Dolezal, Tomas
    Strosova, Daniela
    Fialova, Jorga
    Gkalpakiotis, Spyridon
    CENTRAL EUROPEAN JOURNAL OF PUBLIC HEALTH, 2022, 30 (01) : 46 - 50
12345